4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-23-054757
CEO disposed of 11,318 shares (other)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gline Matthew CEO | 2023-11-22 | Other disposition 10b5-1 | −11,318 | $8.68 | $98,240 | 1,017,433 | D |
Loading xslF345X05/form4.xml…